Acute Kidney Injury in COVID-19: Emerging Evidence of a Distinct Pathophysiology

J Am Soc Nephrol. 2020 Jul;31(7):1380-1383. doi: 10.1681/ASN.2020040419. Epub 2020 May 4.

COVID-19 and ACE2 in Cardiovascular, Lung, and Kidney Working Group:
Matthew A Sparks, Swapnil Hiremath, Daniel Batlle, Andrew South, Paul Welling, J Matt Luther, Jordana Cohen, James Brian Byrd, Louise M Burrell, Laurie Tomlinson, Vivek Bhalla, María José Soler, Sundar Swaminathan, Michelle N Rheault, Sundar Swaminathan

¹ Northwestern University Feinberg School of Medicine, Division of Nephrology and Hypertension, Chicago, Illinois d-batlle@northwestern.edu swami@virginia.edu.
² Hospital Universitari Vall d'Hebron, Division of Nephrology Autonomous University of Barcelona, Barcelona, Spain.
³ Division of Nephrology, Department of Medicine, Duke University School of Medicine, Durham, North Carolina.
⁴ Renal Section, Durham Veterans Affairs Health Care System, Durham, North Carolina.
⁵ Division of Nephrology, Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
⁶ Department of Pediatrics, Section of Nephrology, Wake Forest School of Medicine, Winston Salem, North Carolina.
⁷ School of Medicine, Departments of Medicine and Physiology, Johns Hopkins University, Baltimore, Maryland.
⁸ Division of Nephrology, and Center for Immunity, Inflammation and Regenerative Medicine, University of Virginia, Charlottesville, Virginia d-batlle@northwestern.edu swami@virginia.edu.

No abstract available

Keywords: ACE2; Macrophage; Thrombotic; Acute kidney Injury; COVID-19.

Publication types